Taro Ohba

Funabashi, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Correction: Pterin-based small molecule inhibitor capable of binding to the secondary pocket in the active site of ricin-toxin A chain.

Correction: Pterin-based small molecule inhibitor capable of binding to the secondary pocket in the active site of ricin-toxin A chain.

Journal: PloS one
Published: May 17, 2024

Pterin-based small molecule inhibitor capable of binding to the secondary pocket in the active site of ricin-toxin A chain.

Pterin-based small molecule inhibitor capable of binding to the secondary pocket in the active site of ricin-toxin A chain.

Journal: PloS one
Published: July 25, 2022

Conformational change in ricin toxin A-Chain: A critical factor for inhibitor binding to the secondary pocket.

Conformational change in ricin toxin A-Chain: A critical factor for inhibitor binding to the secondary pocket.

Journal: Biochemical and biophysical research communications
Published: July 22, 2022

Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study).

Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study).

Journal: PloS one
Published: February 29, 2020

Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab.

Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab.

Journal: Journal of thoracic disease
Published: October 28, 2019

Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patients.

Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patients.

Journal: Thoracic cancer
Published: May 27, 2019

Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.

Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.

Journal: Surgery today
Published: September 02, 2015

Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.

Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.

Journal: The Annals of thoracic surgery
Published: February 17, 2013

First case of combined small-cell lung cancer with adenocarcinoma harboring EML4-ALK fusion and an exon 19 EGFR mutation in each histological component.

First case of combined small-cell lung cancer with adenocarcinoma harboring EML4-ALK fusion and an exon 19 EGFR mutation in each histological component.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 17, 2012

Increase of bone morphogenetic protein-7 expressing pulmonary resident cells in pneumonectomized rats.

Increase of bone morphogenetic protein-7 expressing pulmonary resident cells in pneumonectomized rats.

Journal: Surgery today
Published: August 25, 2012

Mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance.

Mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance.

Journal: Surgery today
Published: July 31, 2012

Regression of thymoma associated with a multilocular thymic cyst: report of a case.

Regression of thymoma associated with a multilocular thymic cyst: report of a case.

Journal: Surgery today
Published: July 07, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026